Ginni Filaments Board Approves ₹132 Crore Multi-Segment Capacity Expansion
Ginni Filaments' board approved ₹132 crore in multi-segment expansions on May 5, 2026, covering a new spunlace non-woven line (₹94 crore, 10,000 MT) and solar project (₹13 crore, 3 MW) at Panoli, kitchen roll and medical product capacity (₹10 crore) at CPD Panoli, and cosmetics expansion (₹15 crore, 800 MT) at Haridwar, all financed 25% via internal accruals and 75% via term loans.
*this image is generated using AI for illustrative purposes only.
Ginni Filaments has received board approval for a sweeping multi-segment capacity expansion programme spanning its facilities at Panoli and Haridwar. At its board meeting held on May 5, 2026, the company's directors approved investments totalling ₹132 crore across four distinct projects — covering spunlace non-woven manufacturing, solar power, kitchen roll and medical products, and cosmetics. Each project is to be financed through a combination of internal accruals (25%) and term loans (75%), underscoring the company's structured approach to funding its growth agenda.
Spunlace Non-Woven Expansion at Panoli
The largest component of the approved programme is the addition of a new spunlace line at the Panoli facility. The board has greenlit an investment of ₹94 crore to add 10,000 MT of annual production capacity to the existing 11,000 MT, with the existing unit already operating at over 90% capacity utilisation. The rationale cited is diversification of products and potential growth in demand. The key parameters of this expansion are outlined below:
| Parameter: | Details |
|---|---|
| Existing Capacity (Annual): | 11,000 MT |
| Existing Capacity Utilisation: | 90%+ |
| Proposed Capacity Addition (Annual): | 10,000 MT |
| Timeline: | March 2026 – April 2027 |
| Investment Required: | ₹94 crore |
| Mode of Financing: | Internal accruals – 25%, Term Loan – 75% |
Solar Power Project at Panoli
Alongside the non-woven expansion, the board has also approved a ₹13 crore investment to add 3 MW of solar power capacity at Panoli. The existing 5 MW solar installation is currently under installation. The new solar capacity is intended to provide cost-effective captive power for the new spunlace non-woven line, with completion targeted between May 2026 and April 2027.
| Parameter: | Details |
|---|---|
| Existing Solar Capacity (Annual): | 5 MW |
| Existing Capacity Utilisation: | Under installation |
| Proposed Capacity Addition (Annual): | 3 MW |
| Timeline: | May 2026 – April 2027 |
| Investment Required: | ₹13 crore |
| Mode of Financing: | Internal accruals – 25%, Term Loan – 75% |
CPD Panoli — Kitchen Roll and Medical Products
The board has further approved a ₹10 crore investment at the CPD Panoli unit to expand kitchen roll capacity and introduce new medical product lines. The existing kitchen roll capacity stands at 24,00,000 units annually, currently operating at 60% utilisation. The proposed addition will raise kitchen roll capacity to 50,00,000 units annually. In addition, new machinery with the capacity to convert 600 MT of spunlace non-woven annually will be installed to manufacture medical application products such as gauzes, swabs, and bandages. This expansion is slated for completion between May 2026 and December 2026.
| Parameter: | Details |
|---|---|
| Existing Kitchen Roll Capacity (Annual): | 24,00,000 units |
| Existing Capacity Utilisation: | 60% |
| Proposed Kitchen Roll Capacity Addition (Annual): | 50,00,000 units |
| New Medical Products Conversion Capacity (Annual): | 600 MT spunlace non-woven |
| Timeline: | May 2026 – December 2026 |
| Investment Required: | ₹10 crore |
| Mode of Financing: | Internal accruals – 25%, Term Loan – 75% |
CPD Haridwar — Cosmetics Division Expansion
The fourth approved project involves a significant scale-up of the cosmetics division at the Haridwar facility. The board has sanctioned ₹15 crore to add 800 MT of annual capacity to the existing 200 MT base, which is currently operating at 50% utilisation. The rationale is to cater to growing demand and serve customers requiring larger volumes. This expansion is targeted for completion between May 2026 and March 2027.
| Parameter: | Details |
|---|---|
| Existing Cosmetic Capacity (Annual): | 200 MT |
| Existing Capacity Utilisation: | 50% |
| Proposed Capacity Addition (Annual): | 800 MT |
| Timeline: | May 2026 – March 2027 |
| Investment Required: | ₹15 crore |
| Mode of Financing: | Internal accruals – 25%, Term Loan – 75% |
Investment Summary
The four board-approved projects collectively represent a total investment outlay of ₹132 crore, as summarised below:
| Project: | Location | Investment |
|---|---|---|
| Spunlace Non-Woven New Line: | Panoli | ₹94 crore |
| Solar Power Project: | Panoli | ₹13 crore |
| Kitchen Roll & Medical Products: | CPD Panoli | ₹10 crore |
| Cosmetics Division Expansion: | CPD Haridwar | ₹15 crore |
| Total: | ₹132 crore |
All four projects are subject to requisite approvals and are to be financed through a uniform structure of 25% internal accruals and 75% term loans. The disclosures were made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Historical Stock Returns for Ginni Filaments
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.24% | +3.19% | +4.56% | +12.32% | +17.15% | +39.57% |
With 75% of the ₹132 crore expansion financed through term loans, how might the increased debt burden impact Ginni Filaments' credit ratings and interest coverage ratios in the near term?
Given that the cosmetics division is currently operating at only 50% utilisation, what demand signals or customer commitments justify a 5x capacity expansion at Haridwar?
How could Ginni Filaments' entry into medical products like gauzes, swabs, and bandages position it competitively against established players in the healthcare consumables segment?
17
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
